Page last updated: 2024-11-02

oxprenolol and Hypokalemia

oxprenolol has been researched along with Hypokalemia in 2 studies

Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.

Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"The time course and concentration-effect relationship of terbutaline-induced hypokalemia was studied, using computer-aided pharmacokinetic-dynamic modeling."9.06Beta-2-adrenoceptor-mediated hypokalemia and its abolishment by oxprenolol. ( Jonkers, R; Oosterhuis, B; Van Boxtel, CJ, 1987)
"The time course and concentration-effect relationship of terbutaline-induced hypokalemia was studied, using computer-aided pharmacokinetic-dynamic modeling."5.06Beta-2-adrenoceptor-mediated hypokalemia and its abolishment by oxprenolol. ( Jonkers, R; Oosterhuis, B; Van Boxtel, CJ, 1987)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baronchelli, A1
Agosta, R1
Verdecchia, P1
Bichisao, E1
Jonkers, R1
Van Boxtel, CJ1
Oosterhuis, B1

Trials

2 trials available for oxprenolol and Hypokalemia

ArticleYear
[Advantages of a fixed association of oxprenolol-chlorthalidone, as opposed to chlorthalidone alone, in the treatment of chronic essential arterial hypertension].
    La Clinica terapeutica, 1981, Apr-15, Volume: 97, Issue:1

    Topics: Adult; Aged; Chlorthalidone; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Drug Co

1981
Beta-2-adrenoceptor-mediated hypokalemia and its abolishment by oxprenolol.
    Clinical pharmacology and therapeutics, 1987, Volume: 42, Issue:6

    Topics: Adult; Humans; Hypokalemia; Oxprenolol; Potassium; Receptors, Adrenergic, beta; Terbutaline

1987